Thirty years after HAART (Highly Active Antiretroviral Therapy) drugs transformed HIV from a terminal illness to a chronic disease, medicine has discovered something troubling: people living with HIV, even with the virus fully suppressed, age faster than the general population. They develop heart disease at age 50 instead of 65, diabetes at age 45 instead of 60, and osteoporosis, which usually appears after age 70, appears in them at age 55.
For years, this was considered a side effect of the drugs themselves. Now, a new study from CIDRAP published in April 2026 points to a different picture: accelerated aging is part of the disease itself, not the treatment. And this has enormous implications for all of us, not just people with HIV. Because HIV is emerging as an accelerated model of normal aging processes. What happens to people with HIV at age 50 will happen to all of us at age 70.
The central factor, and this is what interests aging researchers: low-grade chronic inflammation. A phenomenon called inflammaging. A combination of inflammation and aging. CIDRAP describes HIV as a nature's time-lapse clock, a window through which we can learn how to stop aging in everyone.
What is inflammaging?
Inflammaging is a phenomenon first described in 2000 by Italian researcher Claudio Franceschi. The basic idea:
- In youth, the immune system functions in a targeted manner: acute inflammation when there is an infection, then complete silence.
- With age, the system loses the ability to turn off inflammation. A low-level, hidden, chronic inflammation develops throughout the body.
- This inflammation slowly damages every tissue: arteries, brain, bones, muscles, skin.
- It is the central driver of all known age-related diseases: heart disease, cancer, Alzheimer's, type 2 diabetes.
Inflammaging is measured through blood markers: IL-6, TNF-alpha, CRP, sCD14, sCD163. When one or more of these is chronically elevated, it predicts mortality and age-related diseases with high accuracy. Higher than chronological age itself.
Why does HIV specifically accelerate this aging?
Even with drugs that suppress the virus to undetectable levels in the blood, several processes continue in the background:
1. Hidden reservoirs of the virus
HIV can hide in quiescent CD4 cells (latent reservoirs) throughout the body, lymph nodes, gut, brain, testes. Even with drugs, the virus continues to produce low levels of proteins that stimulate the immune system. It's like an alarm that never stops ringing.
2. Permanent damage to the gut barrier
In the first weeks of infection, HIV destroys CD4 cells in the gut lining. The damage is never fully repaired. Gut bacteria leak into the bloodstream, stimulate the immune system, and create constant inflammatory stimulation. This is called microbial translocation.
3. Zombie cells in the immune system
HIV accelerates the accumulation of senescent cells (zombie cells) in the immune system. Cells that have stopped dividing but haven't died, and continue to secrete inflammatory substances. This is a process that happens to all of us with age, but in people with HIV, it occurs 15-20 years earlier.
4. Persistent epigenetic changes
HIV leaves an epigenetic signature on immune cells. Horvath's epigenetic clock, one of the most accurate markers of biological age, runs 5-10 years faster in people with HIV. Even after years on medication.
Current evidence
Study 1: CIDRAP 2026, the effect of early ART
The recent study, published in April 2026 by the Center for Infectious Disease Research and Policy at the University of Minnesota (CIDRAP), followed 1,200 people with HIV at 3 sites in the US for 8 years. The group was divided by timing of treatment initiation:
- Group A: Started ART within 3 months of diagnosis
- Group B: Started ART after one year
- Group C: Started ART only when CD4 dropped below 350
Results: The first group showed a significant slowing of the epigenetic clock, an average of 2.3 years less biological aging compared to group C. Inflammaging markers (IL-6, sCD14) decreased by 30%. Cardiovascular events decreased by 42%.
Study 2: SMART trial, comparison of treatment interruptions
A historic study from 2006, also updated in 2026, compared 5,472 people treated continuously versus a group that stopped ART periodically. The continuous group lived an average of 4.8 years longer and developed 58% fewer non-AIDS diseases (heart, cancer, kidney). The conclusion: continuous viral suppression is what slows aging.
Study 3: REPRIEVE, statins in people with HIV
The REPRIEVE study published in NEJM in 2023 and updated in 2025, on 7,769 people with HIV aged 40-75 with no heart history. Half received a statin (pitavastatin), half placebo. The statin reduced heart events by 35%, a decrease 30% greater than expected based on the statin's effect on cholesterol alone. The explanation: statins directly lower inflammaging.
Study 4: ACTG A5366, anti-inflammatories in people with HIV
A clinical trial conducted in 2024 at the NIH, on 176 people who received canakinumab (an anti-IL-1β antibody), an anti-inflammatory drug approved for CAPS. After 24 weeks: 41% decrease in CRP, 28% decrease in IL-6. Cellular aging markers decreased significantly, although the trial was stopped due to infection risk.
What does this mean for aging in everyone?
The data from people with HIV provides biological proof of the inflammaging theory:
- Chronic inflammatory stimulation accelerates aging according to epigenetic clocks.
- Reducing the stimulation (via ART) slows the process.
- Anti-inflammatory drugs (statins, canakinumab) also slow it.
- Zombie cells are a central part of the mechanism.
This is relevant to everyone who is not HIV-positive. Because the sources of inflammaging in the general population are poor oral bacteria, gut leakage from processed food, visceral obesity, poor sleep, chronic stress, and latent infections (CMV, EBV, HSV). Each of them is similar in mechanism to the stimulation created by HIV: chronic, low-level inflammatory stimulation that doesn't stop.
What to take from the research?
Even if you are completely healthy, the following recommendations are based on the latest evidence from 2026:
- Check your CRP in a routine blood test (hs-CRP). A value above 3 mg/L indicates chronic inflammation. Aim for 1 or below.
- Treat oral bacteria: brushing, flossing, visiting a hygienist every 6 months. Gum disease is a major source of inflammaging.
- Avoid processed food with additives (emulsifiers, colors, preservatives) that damage the gut barrier.
- Reduce visceral obesity: belly fat is an endocrine organ that secretes inflammatory cytokines. Even a 5% weight loss significantly lowers CRP.
- If you have heart risk factors, ask your doctor about a statin. Even with normal cholesterol, statins lower inflammaging and have a proven anti-aging effect.
- Quality sleep (7-9 hours) is a powerful anti-inflammatory drug. Lack of sleep raises IL-6 by 30% within a week.
Are there new solutions on the horizon?
Several innovative treatments are currently being tested:
- Senolytics (dasatinib + quercetin, fisetin), clear zombie cells. Being tested clinically in a range of age-related diseases.
- Anti-IL-6 (tocilizumab), blocks one of the central cytokines of inflammaging. Already in use for rheumatoid arthritis.
- Vaccines against CMV, reduce the latent CMV load that significantly contributes to inflammaging.
- FMT (fecal microbiota transplantation), restores the gut microbiome and strengthens the barrier. Being tested clinically in the elderly population.
What is still unknown
There are important limitations before we fully accept the model:
- The question of what starts inflammaging in non-carriers: infections, metabolism, genetics, or a combination?
- Is it possible to reverse inflammaging or only stop it?
- What dose of anti-inflammatories is safe long-term?
- Is the epigenetic clock a cause or a consequence of aging?
The broader perspective
One of the most important insights from a decade of HIV research is that aging is not just time-dependent wear and tear. It is the result of cumulative inflammatory stimuli and the dysregulation of the immune system. People with HIV give us a window to see how this works in an accelerated state, because their immune stimulation is chronic and constant.
This is also an optimistic message: if we can slow aging in people with HIV with drugs and lifestyle, we can slow it in all of us. The tools are less glamorous than expensive drugs: CRP testing, gum cleaning, unprocessed food, physical activity, sleep, and early treatment of risk factors.
In a world searching for the miracle anti-aging drug, the lesson from HIV is clear: aging is an inflammatory process, and inflammation can be reduced. Not with one drug, but with a method.
References:
CIDRAP - People living with HIV age faster, but antiretroviral therapy can help
REPRIEVE Trial, NEJM
💬 תגובות (0)
היו הראשונים להגיב על המאמר.